Literature DB >> 31003332

Preliminary Estimates of Costs of Foodborne Disease in the United States.

Ewen C D Todd1.   

Abstract

Although the full economic impact of foodborne diseases has yet to be measured, preliminary studies show that the cost of illness, death, and business lost is high indeed. This impact is probably greatest in developing countries, but few facts are known. For the United States, preliminary estimates are 12.6 million cases costing $8.4 billion. These may seem excessive but other authors have postulated even higher case and dollar figures. Microbiological diseases (bacterial and viral) represent 84% of the United States' costs, with salmonellosis and staphylococcal intoxication being the most economically important diseases (annually $4.0 billion and $1.5 billion, respectively). Other costly types of illnesses are toxoplasmosis ($445 million), listeriosis ($313 million), campylobacteriosis ($156 million), trichinosis ($144 million), Clostridium perfringens enteritis ($123 million), and E. coli infections including hemorrhagic colitis ($223 million). Botulism has a high cost per case ($322,200), but its total impact is only $87 million because relatively few cases occur (270). This is because the food industry has been able to introduce effective control measures. Salmonellosis, however, is much more widespread (2.9 million cases) and affects all sectors of the food industry.

Entities:  

Year:  1989        PMID: 31003332     DOI: 10.4315/0362-028X-52.8.595

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  2 in total

1.  The occurrence of Salmonella in airline meals.

Authors:  M Hatakka; K Asplund
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

Review 2.  Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact.

Authors:  S Stelzer; W Basso; J Benavides Silván; L M Ortega-Mora; P Maksimov; J Gethmann; F J Conraths; G Schares
Journal:  Food Waterborne Parasitol       Date:  2019-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.